Offer Letter for Principal Financial Officer Position between Proteostasis Therapeutics, Inc. and Sandra Zimmerman
Proteostasis Therapeutics, Inc. offers Sandra Zimmerman the position of Principal Financial Officer, effective August 6, 2018. This letter supplements, but does not change, the existing Consulting Agreement between the company and Danforth Advisors, LLC. Sandra's role as Principal Financial Officer will continue at the discretion of the Board of Directors. The agreement is confirmed by Sandra's signature, indicating her acceptance of the offer.
Exhibit 10.5
80 Guest Street, Fifth Floor
Boston, MA 02135
August 3, 2018
PERSONAL AND CONFIDENTIAL
Sandra Zimmerman
c/o Proteostasis Therapeutics, Inc.
80 Guest Street, 5th Floor
Boston, MA 02135
Dear Ms. Zimmerman:
Proteostasis Therapeutics, Inc. (the "Company" ) is pleased to offer you the position of Principal Financial Officer to the Company, effective August 6, 2018.
The terms of this offer letter shall supplement those in the Consulting Agreement by and between the Company and Danforth Advisors, LLC, a Massachusetts limited liability corporation, dated May 7, 2018 (the "Consulting Agreement") and nothing in this offer letter will amend, modify or supersede the Consulting Agreement.
Your engagement as Principal Financial Officer will continue at the pleasure of the Board of Directors.
This offer letter may be signed in one or more counterparts.
We are excited about the prospect of having you serve as Principal Financial Officer to the Company. We look forward to receiving a response from you, acknowledging by signing below, that you have accepted this offer.
| Sincerely, | ||
|
|
|
|
| PROTEOSTASIS THERAPEUTICS, INC. | ||
|
|
|
|
| By: |
| /s/ Meenu Chhabra |
|
|
| Meenu Chhabra |
|
|
| President & CEO |
| ACCEPTED AND AGREED ON THE DATE SET FORTH BELOW: | ||
|
|
|
|
| By: |
| /s/ Sandra Zimmerman |
|
|
| Sandra Zimmerman |
Date: August 3, 2018
